Houston (1)

Blasts Under 15 Percent of Bone Marrow Nucleated Cells (1)

Blasts Under 15 Percent of Peripheral Blood White Cells (1)

Blasts Under 30 Percent of Bone Marrow Nucleated Cells (1)

Blasts Under 30 Percent of Peripheral Blood White Cells (1)

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (1)

Terminated (1)

phase 2 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

Pfizer (1)

bosutinib (1)

laboratory biomarker analysis (1)

drug (1)

other (1)

Other (1)

Interventional (1)

blasts under 15 percent of bone marrow nucleated cells

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Apr 22, 2020